Literature DB >> 6638994

Resistance of gram-negative bacilli as related to hospital use of antimicrobial agents.

M Y Ma, E J Goldstein, M H Friedman, M S Anderson, M E Mulligan.   

Abstract

The development of resistance of gram-negative bacilli, which are common nosocomial pathogens, is an increasing problem. It is generally accepted that this resistance may directly reflect the frequency of use of various antimicrobial agents. Because our institution experienced in 1976 a dramatic change in the pattern of antimicrobial use, primarily a marked decrease in prescribing cephalosporins, we attempted to evaluate retrospectively the effects of this change upon the resistance of gram-negative bacilli that are common nosocomial pathogens. Susceptibilities of Klebsiella and Providencia spp., Pseudomonas aeruginosa, and Serratia marcescens were determined for the years 1975 to 1979. Not unexpectedly, we observed a substantial decrease in cephalosporin resistance. An unexpected finding was a decrease in aminoglycoside resistance, despite increased use of these agents. The possibility that decreased cephalosporin use may lead to decreased aminoglycoside resistance is an intriguing and provocative thesis which can only be speculative at this time but which would seem worthy of additional formal investigation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6638994      PMCID: PMC185324          DOI: 10.1128/AAC.24.3.347

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.

Authors:  R C Moellering; C Wennersten; L J Kunz; J W Poitras
Journal:  Am J Med       Date:  1977-06       Impact factor: 4.965

2.  Nosocomial bloodstream infections caused by gentamicin-resistant gram-negative bacilli.

Authors:  R L Guerrant; L J Strausbaugh; R P Wenzel; B H Hamory; M A Sande
Journal:  Am J Med       Date:  1977-06       Impact factor: 4.965

3.  Decreased incidences of resistance to antimicrobial agents among Escherichia coli and Klebsiella-enterobacter. Observations in a university hospital over a 10-year period.

Authors:  R J Bulger; E Larson; J C Sherris
Journal:  Ann Intern Med       Date:  1970-01       Impact factor: 25.391

Review 4.  Changing patterns of susceptibility of common bacterial pathogens to antimicrobial agents.

Authors:  M Finland
Journal:  Ann Intern Med       Date:  1972-06       Impact factor: 25.391

5.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

6.  An educational program for the rational use of antimicrobial agents.

Authors:  J W Smith; S R Jones
Journal:  South Med J       Date:  1977-02       Impact factor: 0.954

7.  Relation of the inanimate hospital environment to endemic nosocomial infection.

Authors:  D G Maki; C J Alvarado; C A Hassemer; M A Zilz
Journal:  N Engl J Med       Date:  1982-12-16       Impact factor: 91.245

8.  Control of infection due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics.

Authors:  D J Price; J D Sleigh
Journal:  Lancet       Date:  1970-12-12       Impact factor: 79.321

9.  Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center.

Authors:  W H Greene; M Moody; S Schimpff; V M Young; P H Wiernik
Journal:  Ann Intern Med       Date:  1973-11       Impact factor: 25.391

10.  The emergence of gentamicin-resistant klebsiellae in a large general hospital.

Authors:  I Forbes; A Gray; A Hurse; R Pavillard
Journal:  Med J Aust       Date:  1977 Jan 1-8       Impact factor: 7.738

View more
  10 in total

1.  Differences in antimicrobial susceptibilities of clinical isolates in Saudi Arabia and the United States.

Authors:  S M Qadri; S Ostrawski; S Johnson; D J Flournoy
Journal:  J Natl Med Assoc       Date:  1987-04       Impact factor: 1.798

2.  A regional survey of the resistance to beta-lactam antibiotics in clinical isolates of (facultative) aerobic micro-organisms.

Authors:  E E Stobberingh; J M Philips; A W Houben; C P van Boven
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Three-year survey of amikacin use and aminoglycoside resistance in a general hospital in Belgium.

Authors:  R Vanhoof; J M Hubrechts; H J Nyssen; E Roebben
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

4.  Antimicrobial drug use in hospitals in The Netherlands, Germany and Belgium.

Authors:  R Janknegt; W J Wijnands; M Caprasse; W Brandenburg; M G Schuitenmaker; E Stobberingh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-11       Impact factor: 3.267

5.  Antimicrobial agent susceptibility patterns of bacteria in hospitals from 1971 to 1982.

Authors:  B A Atkinson; V Lorian
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

6.  Plasmid-specified aminoglycoside-modifying enzymes in clinical isolates of Klebsiella pneumoniae.

Authors:  B Facinelli; M P Montanari; L Calegari
Journal:  Eur J Epidemiol       Date:  1985-03       Impact factor: 8.082

7.  In vitro comparison of amifloxacin and six other antibiotics against aminoglycoside-resistant Pseudomonas aeruginosa.

Authors:  K D Thompson; J P O'Keefe; W A Tatarowicz
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

8.  The prevalence of antibiotic-resistant faecal Escherichia coli in healthy volunteers in Venezuela.

Authors:  H J van de Mortel; E J Jansen; G J Dinant; N London; E Palacios Prü; E E Stobberingh
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

9.  Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

10.  A decision support tool for antibiotic therapy.

Authors:  R S Evans; D C Classen; S L Pestotnik; T P Clemmer; L K Weaver; J P Burke
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1995
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.